- 1-Benzopyrylium,2-(3,4-dihydroxyphenyl)-3-(b-D-glucopyranosyloxy)-5,7-dihydroxy-, chloride (1:1)
- 1-Benzopyrylium,2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-
- 1-Benzopyrylium,3,5-bis(b-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxyphenyl)-,chloride (1:1)
- 7084-29-9Uridine,3'-deoxy-5-methyl- (7CI,9CI)
- 70849-23-9D-Arabinose-1-13C (9CI)
- 70849-24-0D-Ribose-1-13C (9CI)
- 70849-25-1D-Gulose-1-13C (9CI)
- 70849-30-8D-Galactose-1-13C
- 70849-60-4N-(2-Methylphenyl)piperazine hydrochloride
- 70849-64-8Piperazine, 1-(4-methoxyphenyl)-, hydrochloride (1:?)
- 70851-07-9Amides, coco, N-(3-(dimethylamino)propyl), alkylation products withchloroacetic acid, sodium salts
- 70851-08-0Amides, coco, N-(3-(dimethylamino)propyl), alkylation products with sodium 3-chloro-2-hydroxypropanesulfonate
- 70851-41-1Xanthylium, 9-(2-carboxyphenyl)-3,6-bis(diethylamino)-, hydrogen bis(3-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-2-hydroxy-5-nitrobenzenesulfonato(3-))chromate(3-) (1:2:1), compd. with 3-((2-butylhexyl)oxy)-1-propanamine (1:1)
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
1-Benzopyrylium,2-(3,4-dihydroxyphenyl)-3-(b-D-glucopyranosyloxy)-5,7-dihydroxy-, chloride (1:1) |
EINECS | 230-384-7 |
| CAS No. | 7084-24-4 | Density | N/A |
| PSA | 193.44000 | LogP | -2.61400 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C21H21O11.Cl | Boiling Point | N/A |
| Molecular Weight | 484.844 | Flash Point | N/A |
| Transport Information | N/A | Appearance | N/A |
| Safety | 24/25 | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
1-Benzopyrylium,2-(3,4-dihydroxyphenyl)-3-(b-D-glucopyranosyloxy)-5,7-dihydroxy-, chloride (9CI);Chrysanthemin(6CI,8CI);3,3',4',5,7-Pentahydroxyflavylium chloride, 3-glucoside;3-(b-D-Glucopyranosyloxy)-3',4',5,7-tetrahydroxyflavyliumchloride;3-O-(b-D-Glucopyranosyl)cyanidin;Asterin;Chrysontemin;Cyanidin 3-O-glucoside;Cyanidin 3-O-b-D-glucopyranoside;Cyanidin 3-O-b-glucopyranoside;Cyanidin3-glucoside;Cyanidin 3-monoglucoside;Cyanidin 3-b-D-glucopyranoside;Cyanidin 3-b-O-glucoside;Cyanidin 3-b-glucopyranoside;Cyanidin 3-b-glucoside;Cyanidol 3-glucoside;Glucocyanidin;Kuromanin;Kuromanine; |
Article Data | 6 |
1-Benzopyrylium,2-(3,4-dihydroxyphenyl)-3-(b-D-glucopyranosyloxy)-5,7-dihydroxy-, chloride (1:1) Specification
The 1-Benzopyrylium,2-(3,4-dihydroxyphenyl)-3-(b-D-glucopyranosyloxy)-5,7-dihydroxy-, chloride (1:1), with CAS registry number 7084-24-4, has the systematic name of 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenium-3-yl β-D-glucopyranoside chloride. This chemical belongs to the following product category: Anthocyanins. This chemical should be stored at the temperature of −20°C. Its classification code is Drug / Therapeutic Agent.
Physical properties of 1-Benzopyrylium,2-(3,4-dihydroxyphenyl)-3-(b-D-glucopyranosyloxy)-5,7-dihydroxy-, chloride (1:1): (1)#H bond acceptors: 11; (2)#H bond donors: 8; (3)#Freely Rotating Bonds: 12; (4)Polar Surface Area: 105.44 Å2.
You can still convert the following datas into molecular structure:
(1)SMILES: [Cl-].O(c1c([o+]c2c(c1)c(O)cc(O)c2)c3ccc(O)c(O)c3)[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO
(2)InChI: InChI=1/C21H20O11.ClH/c22-7-16-17(27)18(28)19(29)21(32-16)31-15-6-10-12(25)4-9(23)5-14(10)30-20(15)8-1-2-11(24)13(26)3-8;/h1-6,16-19,21-22,27-29H,7H2,(H3-,23,24,25,26);1H/t16-,17-,18+,19-,21-;/m1./s1
(3)InChIKey: YTMNONATNXDQJF-UBNZBFALBB
(4)Std. InChI: InChI=1S/C21H20O11.ClH/c22-7-16-17(27)18(28)19(29)21(32-16)31-15-6-10-12(25)4-9(23)5-14(10)30-20(15)8-1-2-11(24)13(26)3-8;/h1-6,16-19,21-22,27-29H,7H2,(H3-,23,24,25,26);1H/t16-,17-,18+,19-,21-;/m1./s1
(5)Std. InChIKey: YTMNONATNXDQJF-UBNZBFALSA-N
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| rat | LD50 | intraperitoneal | 2gm/kg (2000mg/kg) | United States Patent Document. Vol. #4229439, |
What can I do for you?
Get Best Price
